NO990283L - Formulering for behandling og/eller profylakse av demens - Google Patents
Formulering for behandling og/eller profylakse av demensInfo
- Publication number
- NO990283L NO990283L NO990283A NO990283A NO990283L NO 990283 L NO990283 L NO 990283L NO 990283 A NO990283 A NO 990283A NO 990283 A NO990283 A NO 990283A NO 990283 L NO990283 L NO 990283L
- Authority
- NO
- Norway
- Prior art keywords
- dementia
- treatment
- prophylaxis
- formulation
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9615628.6A GB9615628D0 (en) | 1996-07-25 | 1996-07-25 | Formulation |
| PCT/EP1997/003872 WO1998004258A1 (en) | 1996-07-25 | 1997-07-14 | Formulation for the treatment and/or prophylaxis of dementia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO990283D0 NO990283D0 (no) | 1999-01-22 |
| NO990283L true NO990283L (no) | 1999-03-19 |
Family
ID=10797487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO990283A NO990283L (no) | 1996-07-25 | 1999-01-22 | Formulering for behandling og/eller profylakse av demens |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0918521B1 (cs) |
| JP (1) | JP2000515868A (cs) |
| KR (1) | KR20000029523A (cs) |
| CN (1) | CN1226163A (cs) |
| AR (1) | AR007983A1 (cs) |
| AT (1) | ATE224711T1 (cs) |
| BR (1) | BR9710546A (cs) |
| CA (1) | CA2261233A1 (cs) |
| CO (1) | CO5031290A1 (cs) |
| CZ (1) | CZ22799A3 (cs) |
| DE (1) | DE69715878T2 (cs) |
| DK (1) | DK0918521T3 (cs) |
| ES (1) | ES2184121T3 (cs) |
| GB (1) | GB9615628D0 (cs) |
| HK (1) | HK1021314A1 (cs) |
| IL (1) | IL128095A (cs) |
| NO (1) | NO990283L (cs) |
| NZ (1) | NZ333704A (cs) |
| PL (1) | PL331283A1 (cs) |
| PT (1) | PT918521E (cs) |
| TR (1) | TR199900141T2 (cs) |
| TW (1) | TW426514B (cs) |
| WO (1) | WO1998004258A1 (cs) |
| ZA (1) | ZA976592B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9815383D0 (en) * | 1998-07-15 | 1998-09-16 | Smithkline Beecham Plc | Novel method of treatment |
| AU2002211067A1 (en) * | 2000-09-27 | 2002-04-08 | Dsm N.V. | Process for the carbonylation of a conjugated diene |
| GB0428170D0 (en) * | 2004-12-23 | 2005-01-26 | Biopartners Ltd | Mono and Combination Therapy |
| JP7293560B2 (ja) | 2017-12-29 | 2023-06-20 | グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド | 芳香族ビニルまたは芳香族エチル系誘導体、その製造方法、中間体、薬物組成物および使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0392803B1 (en) * | 1989-04-13 | 2004-06-16 | Beecham Group p.l.c. | Novel compounds |
| MX9300875A (es) * | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
| GB9409705D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
| DE19501022C1 (de) * | 1995-01-14 | 1996-06-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
-
1996
- 1996-07-25 GB GBGB9615628.6A patent/GB9615628D0/en active Pending
-
1997
- 1997-07-14 NZ NZ333704A patent/NZ333704A/en unknown
- 1997-07-14 EP EP97934492A patent/EP0918521B1/en not_active Expired - Lifetime
- 1997-07-14 KR KR1019997000576A patent/KR20000029523A/ko not_active Application Discontinuation
- 1997-07-14 IL IL12809597A patent/IL128095A/en not_active IP Right Cessation
- 1997-07-14 CA CA002261233A patent/CA2261233A1/en not_active Abandoned
- 1997-07-14 ES ES97934492T patent/ES2184121T3/es not_active Expired - Lifetime
- 1997-07-14 WO PCT/EP1997/003872 patent/WO1998004258A1/en not_active Application Discontinuation
- 1997-07-14 DK DK97934492T patent/DK0918521T3/da active
- 1997-07-14 BR BR9710546A patent/BR9710546A/pt unknown
- 1997-07-14 PL PL97331283A patent/PL331283A1/xx unknown
- 1997-07-14 JP JP10508451A patent/JP2000515868A/ja active Pending
- 1997-07-14 CN CN97196687A patent/CN1226163A/zh active Pending
- 1997-07-14 CZ CZ99227A patent/CZ22799A3/cs unknown
- 1997-07-14 AT AT97934492T patent/ATE224711T1/de not_active IP Right Cessation
- 1997-07-14 DE DE69715878T patent/DE69715878T2/de not_active Expired - Fee Related
- 1997-07-14 PT PT97934492T patent/PT918521E/pt unknown
- 1997-07-14 TR TR1999/00141T patent/TR199900141T2/xx unknown
- 1997-07-23 AR ARP970103327A patent/AR007983A1/es unknown
- 1997-07-24 ZA ZA976592A patent/ZA976592B/xx unknown
- 1997-07-24 TW TW086110515A patent/TW426514B/zh not_active IP Right Cessation
- 1997-07-25 CO CO97042583A patent/CO5031290A1/es unknown
-
1999
- 1999-01-22 NO NO990283A patent/NO990283L/no unknown
- 1999-12-01 HK HK99105593A patent/HK1021314A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR007983A1 (es) | 1999-11-24 |
| KR20000029523A (ko) | 2000-05-25 |
| PT918521E (pt) | 2003-02-28 |
| IL128095A (en) | 2002-07-25 |
| DK0918521T3 (da) | 2003-02-03 |
| TR199900141T2 (xx) | 1999-03-22 |
| JP2000515868A (ja) | 2000-11-28 |
| BR9710546A (pt) | 1999-08-17 |
| CZ22799A3 (cs) | 1999-06-16 |
| NZ333704A (en) | 2000-06-23 |
| IL128095A0 (en) | 1999-11-30 |
| GB9615628D0 (en) | 1996-09-04 |
| CO5031290A1 (es) | 2001-04-27 |
| CA2261233A1 (en) | 1998-02-05 |
| HK1021314A1 (en) | 2000-06-09 |
| CN1226163A (zh) | 1999-08-18 |
| ATE224711T1 (de) | 2002-10-15 |
| TW426514B (en) | 2001-03-21 |
| WO1998004258A1 (en) | 1998-02-05 |
| DE69715878D1 (de) | 2002-10-31 |
| ZA976592B (en) | 1999-03-04 |
| EP0918521B1 (en) | 2002-09-25 |
| AU721101B2 (en) | 2000-06-22 |
| AU3768497A (en) | 1998-02-20 |
| DE69715878T2 (de) | 2003-05-22 |
| ES2184121T3 (es) | 2003-04-01 |
| EP0918521A1 (en) | 1999-06-02 |
| NO990283D0 (no) | 1999-01-22 |
| PL331283A1 (en) | 1999-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2725392A (en) | Hiv protease inhibitors | |
| CA2179540A1 (en) | Accelerated release composition containing bromocriptine | |
| SI0725779T1 (cs) | ||
| AU1266288A (en) | Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| UA35604C2 (uk) | Фармацевтична композиція з антидепресивною активністю | |
| DE59608698D1 (de) | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure | |
| ATE219061T1 (de) | Huperzin a analoge verbindungen | |
| HUP0004282A2 (hu) | 2-Halogén-6-0-szubsztituált ketolidszármazékok | |
| AU1277792A (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts | |
| NO892820L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater. | |
| NO990283L (no) | Formulering for behandling og/eller profylakse av demens | |
| MX9705916A (es) | Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc. | |
| CA2120319A1 (en) | Pharmaceutical for the treatment of skin disorders | |
| CA2003981A1 (en) | Pharmaceutical compositions and use thereof in the treatment of psoriasis | |
| MX9700036A (es) | Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas. | |
| AU6970394A (en) | Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2 | |
| NO952234L (no) | Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| NO167982C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater. | |
| NO922635L (no) | Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater | |
| AP9200405A0 (en) | Pharmaceutical formulations comprised of micronised halofantrine. | |
| GB9323404D0 (en) | Pharmaceuticals | |
| AU3429393A (en) | Pharmaceutical pentapeptide compositions and methods of use thereof | |
| WO1994016705A3 (en) | Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |